story of the week
Use of Serum Biomarkers at Disease Onset for Personalized Therapy in Patients With MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Brain: A Journal of Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Serum biomarkers at disease onset for personalized therapy in multiple sclerosis
Brain 2024 Aug 05;[EPub Ahead of Print], E Monreal, JI Fernández-Velasco, R Álvarez-Lafuente, S Sainz de la Maza, MI García-Sánchez, S Llufriu, B Casanova, M Comabella, S Martínez-Yélamos, D Galimberti, L Ramió-Torrentà, ML Martínez-Ginés, Y Aladro, L Ayuso, JE Martínez-Rodríguez, L Brieva, N Villarrubia, S Eichau, J Zamora, A Rodero-Romero, M Espiño, Y Blanco, A Saiz, X Montalbán, M Tintoré, MI Domínguez-Mozo, JP Cuello, L Romero-Pinel, L Ghezzi, B Pilo de la Fuente, F Pérez-Miralles, A Quiroga-Varela, L Rubio, F Rodríguez-Jorge, JL Chico-García, R Sainz-Amo, J Masjuan, L Costa-Frossard, LM VillarFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.